Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
China channel feed
Trump’s tariff impact likely ‘minimal’ for brand-name drugmakers, manufacturing partners
4 months ago
Pharma
Manufacturing
Post-Hoc: China tensions both help and hurt Illumina
5 months ago
Diagnostics
AstraZeneca offers some detail on China probe, reaffirms commitment to that market
5 months ago
Pharma
Law
Merck CEO says he’s confident in growth despite Gardasil ‘headwind’
5 months ago
Pharma
Illumina added to China's blacklist following Biosecure Act, tariffs
5 months ago
Pharma
Updated: Merck temporarily pauses Gardasil shipments to China following sales slowdown
5 months ago
Pharma
Biogen’s revised research strategy is to avoid becoming obsolete, top exec says
5 months ago
Deals
R&D
Novo Nordisk’s amycretin prompts 22% weight loss in early obesity trial
5 months ago
R&D
Chinese startup begins first trial of in vivo CRISPR therapy for blood disease
5 months ago
R&D
Cell/Gene Tx
Oncology biotech ArriVent does another China ADC deal, this time with Lepu Biopharma
5 months ago
Startups
Deals
China's biotech boom is threatening US drugmakers' dominance
5 months ago
R&D
In Focus
Ascentage estimates $133M in proceeds as it plans Nasdaq dual listing
5 months ago
Financing
Another US biotech emerges with drug candidate from China-based Keymed
5 months ago
Startups
Deals
Post-Hoc: The embryo editing debate is back
5 months ago
Cell/Gene Tx
Lawmakers ask Biden administration to tighten rules around China clinical trials
6 months ago
Pharma
Law
Four biotechs emerge with $800M and in-licensed assets on Friday
6 months ago
Financing
Deals
Another biotech scoops up asset from China-based Keymed and nabs $180M
6 months ago
Startups
Deals
Exclusive: Avenzo picks up another ADC, this time with multi-partnered DualityBio
6 months ago
Startups
Deals
WuXi Biologics to sell Irish vaccine site to Merck for $500M
6 months ago
Manufacturing
WuXi AppTec will sell cell and gene therapy business to private equity firm
6 months ago
Cell/Gene Tx
Manufacturing
Post-Hoc: Biosecure is dead. Long live Biosecure?
6 months ago
Editor's note
Manufacturing
Merck’s long-awaited obesity move is an oral GLP-1 from China
6 months ago
Deals
Pharma
The Endpoints 100: The biotech industry braces for Trump 2.0
7 months ago
Deals
Bioregnum
Exclusive: Bain-backed musculoskeletal biotech raises $120M for trio of clinical-stage biologics
7 months ago
Financing
Startups
First page
Previous page
1
2
3
4
5
6
Next page
Last page
